Methylation of MGMT gene promoter was more frequently found in GBMs than in grade III gliomas (P < 0.0017 by Chi-square) and it was significantly associated with better OS and DFS in GBM (P < 0.0001 and P = 0.0001, resp). The gene discussed is MGMT; the disease is central nervous system cancer.